Hostname: page-component-848d4c4894-p2v8j Total loading time: 0 Render date: 2024-04-30T19:44:13.844Z Has data issue: false hasContentIssue false

Incomplete endothelialisation of an Amplatzer Septal Occluder device followed by meningitis and late acute bacterial endocarditis

Published online by Cambridge University Press:  28 December 2015

Jacek Białkowski
Affiliation:
Department of Congenital Heart Diseases and Pediatric Cardiology, Silesian Center for Heart Diseases, Medical University of Silesia, Zabrze, Poland
Szymon Pawlak
Affiliation:
Department of Transplantology and Cardiac Surgery, Silesian Center for Heart Diseases, Medical University of Silesia, Zabrze, Poland
Paweł Banaszak*
Affiliation:
Department of Congenital Heart Diseases and Pediatric Cardiology, Silesian Center for Heart Diseases, Medical University of Silesia, Zabrze, Poland
*
Correspondence to: P. Banaszak, Department of Congenital Heart Diseases and Pediatric Cardiology, Silesian Center for Heart Diseases, Medical University of Silesia, Curie-Sklodowskiej 9, 41-800 Zabrze, Poland. Tel/Fax: +48 32 2713401; E-mail: rhplus@op.pl

Abstract

A 19-year-old woman with atrial septal defect treated percutaneously with an Amplatzer Septal Occluder 24 months earlier, who presented with a history of bacterial meningitis, was admitted with a diagnosis of endocarditis. After 6 weeks of treatment with antibiotics, the incompletely endothelialised occluder was surgically removed. The present report illustrates the need for long-term follow-up of patients who have received nitinol wire mesh occluders.

Type
Brief Reports
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Masura, J, Gavora, P, Podnar, T. Long-term outcome of transcatheter secundum-type atrial septal closure using Amplatzer septal occluders. J Am Coll Cardiol 2005; 45: 505507.Google Scholar
2. Majunke, N, Bialkowski, J, Wilson, N, et al. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol 2009; 103: 550554.Google Scholar
3. Slesnick, T, Neugent, AW, Fraser, CD, Cannon, BC. Incomplete endothelialization and late development of acute bacterial endocarditis after implantation of an Amplatzer septal occluder device. Circulation 2008; 117: e326e327.Google Scholar
4. Zahr, F, Katz, WE, Toyoda, Y, Anderson, WD. Late bacterial endocarditis of an Amplatzer septal defect occluder device. Am J Cardiol 2010; 105: 279280.Google Scholar
5. Aruni, B, Sharifian, A, Herrera, CJ. Late bacterial endocarditis of an Amplatzer atrial septal device. Indian Heart J 2013; 65: 450451.Google Scholar
6. Wilson, W, Taubert, KA, Gewitz, M, et al. AHA guideline prevention of infective endocarditis guidelines from American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesiology, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 17361754.Google Scholar
7. Balasundaram, RP, Anandaraja, S, Juneja, R, Choudhary, SK. Infective endocarditis following implantation of Amplatzer atrial septal occluder. Indian Heart J 2005; 57: 167169.Google Scholar
8. Bullock, AM, Menahem, S, Wilkinson, JL. Infective endocarditis on an occluder closing an atrial septal defect. Cardiol Young 1999; 9: 6567.Google Scholar